Today's Daily Dose brings you news about Acasti Pharma's phase III trial of CaPre, Merger Monday, CorMedix's regulatory catalyst, Vanda Pharma's anticipated milestones, and the progress in Vir/Glaxo's COVID-19 trial.
from RTT - Biotech https://ift.tt/3jAjgkG
via IFTTT
Read More »
from RTT - Biotech https://ift.tt/3jAjgkG
via IFTTT